PMID- 30450663 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230201 IS - 1097-4644 (Electronic) IS - 0730-2312 (Linking) VI - 120 IP - 5 DP - 2019 May TI - Activation of the mammalian target of rapamycin signaling pathway underlies a novel inhibitory role of ring finger protein 182 in ventricular remodeling after myocardial ischemia-reperfusion injury. PG - 7635-7648 LID - 10.1002/jcb.28038 [doi] AB - Myocardial ischemia-reperfusion injury (MIRI) is a major cause of cardiovascular disease, leading to mortality and disability associated with coronary occlusion worldwide. A correlation of mammalian target of rapamycin (mTOR)/nuclear factor-kappa B (NF-kappaB) signaling pathway has been observed with brain damage resulting from myocardial ischemia. Therefore, by establishing MIRI rat model, this study aimed to explore whether ring finger protein 182 (RNF182) regulates the mTOR signaling pathway affecting MIRI. Initially, MIRI rat model was successfully established, followed by either treatment of shRNF182 or phosphoesterase (PITE) (inhibitor of the mTOR signaling pathway). Then, the serum levels of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and malondialdehyde (MDA), left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), left ventricular systolic pressure (LVSP), and left ventricular end-diastolic pressure (LVEDP) were determined, followed by detection of myocardial infarct sizes and myocardial cell apoptosis. Moreover, the levels of related genes/proteins were determined to further determine the mechanisms of RNF182 in MIRI. First, RNF182 was upregulated in MIRI. Another key observation of this study was that rats with shRNF182 presented with downregulated SOD, GSH-Px, and MDA in serum, accompanied by decreased levels of LVEF, LVFS, LVSP, and LVEDP. In addition, both reduced myocardial infarct sizes and apoptosis of myocardial cells were observed after silencing RNF182. Furthermore, silencing of the RNF182 was observed to downregulate Bcl 2-associated X and cysteine proteinase 3 but upregulate mTOR, ribosome protein subunit 6 kinase 1, eukaryotic elongation factor 2, and B-cell lymphoma-2. Importantly, the effects of RNF182 silencing were reversed after PITE treatment. In conclusion, our study demonstrates that RNF182 silencing can prevent ventricular remodeling in rats after MIRI by activating the mTOR signaling pathway. CI - (c) 2018 Wiley Periodicals, Inc. FAU - Wang, Jing-Hua AU - Wang JH AD - Department of Pediatric Rheumatology, Immunology and Allergy, The First Hospital of Jilin University, Changchun, China. FAU - Wei, Zhi-Feng AU - Wei ZF AD - Department of Cardiology, FAW General Hospital, Changchun, China. FAU - Gao, Yan-Li AU - Gao YL AD - Department of Science and Education, The First Hospital of Jilin University, Changchun, China. FAU - Liu, Cong-Cong AU - Liu CC AD - Department of Pediatric Rheumatology, Immunology and Allergy, The First Hospital of Jilin University, Changchun, China. FAU - Sun, Jing-Hui AU - Sun JH AUID- ORCID: 0000-0001-6040-489X AD - Department of Pediatric Cardiology, The First Hospital of Jilin University, Changchun, China. LA - eng PT - Journal Article DEP - 20181118 PL - United States TA - J Cell Biochem JT - Journal of cellular biochemistry JID - 8205768 SB - IM OTO - NOTNLM OT - gene silencing OT - mammalian target of rapamycin (mTOR) signaling pathway OT - myocardial ischemia-reperfusion injury (MIRI) OT - ring finger protein 182 (RNF182) OT - ventricular remodeling EDAT- 2018/11/20 06:00 MHDA- 2018/11/20 06:01 CRDT- 2018/11/20 06:00 PHST- 2018/07/09 00:00 [received] PHST- 2018/10/15 00:00 [accepted] PHST- 2018/11/20 06:00 [pubmed] PHST- 2018/11/20 06:01 [medline] PHST- 2018/11/20 06:00 [entrez] AID - 10.1002/jcb.28038 [doi] PST - ppublish SO - J Cell Biochem. 2019 May;120(5):7635-7648. doi: 10.1002/jcb.28038. Epub 2018 Nov 18.